Melanoma

Regimen Shows Benefit for Advanced Melanoma

A minimal, less-toxic conditioning treatment with cyclophosphamide, which allows cytotoxic T-lymphocyte clones to survive for longer, shows some clinical benefit in patients with refractory, metastatic melanoma.

Next post in Skin Cancer